Literature DB >> 7913096

Epidemic spread of Shigella sonnei shigellosis and evidence for development of immunity among children attending day-care centers in a communal settlement (Kibbutz).

Y Lerman1, M Yavzori, R Ambar, I Sechter, M Wiener, D Cohen.   

Abstract

An investigation of two Shigella sonnei shigellosis outbreaks that occurred in a communal settlement indicated that the transmission of the pathogen was restricted to day-care classes and secondary infection of family members was minimal. Development of serotype-specific immunity following S. sonnei infection was observed among infected children.

Entities:  

Mesh：

Year:  1994        PMID： 7913096      PMCID： PMC267193          DOI： 10.1128/jcm.32.4.1092-1094.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

1.  Inoculum size in shigellosis and implications for expected mode of transmission.

Authors:  H L DuPont; M M Levine; R B Hornick; S B Formal
Journal:  J Infect Dis       Date:  1989-06       Impact factor: 5.226

2.  Natural immunity to shigellosis in two groups with different previous risks of exposure to Shigella is only partly expressed by serum antibodies to lipopolysaccharide.

Authors:  D Cohen; M S Green; C Block; R Slepon; Y Lerman
Journal:  J Infect Dis       Date:  1992-04       Impact factor: 5.226

3.  Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection.

Authors:  H L DuPont; R B Hornick; M J Snyder; J P Libonati; S B Formal; E J Gangarosa
Journal:  J Infect Dis       Date:  1972-01       Impact factor: 5.226

4.  Shigellosis in day care centers: use of plasmid analysis to assess control measures.

Authors:  C O Tacket; M L Cohen
Journal:  Pediatr Infect Dis       Date:  1983 Mar-Apr

5.  Family illness associated with Shigella infection: the interrelationship of age of the index patient and the age of household members in acquisition of illness.

Authors:  R Wilson; R A Feldman; J Davis; M LaVenture
Journal:  J Infect Dis       Date:  1981-01       Impact factor: 5.226

6.  Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease.

Authors:  D A Herrington; L Van de Verg; S B Formal; T L Hale; B D Tall; S J Cryz; E C Tramont; M M Levine
Journal:  Vaccine       Date:  1990-08       Impact factor: 3.641

7.  Molecular epidemiology of Shigella infections in Israel.

Authors:  M Yavzori; D Cohen; H Bercovier
Journal:  Epidemiol Infect       Date:  1992-10       Impact factor: 2.451

8.  Shigellosis in day-care centres.

Authors:  J B Weissman; E J Gangorosa; A Schmerler; R L Marier; J N Lewis
Journal:  Lancet       Date:  1975-01-11       Impact factor: 79.321

9.  Diarrhea caused by Shigella, rotavirus, and Giardia in day-care centers: prospective study.

Authors:  L K Pickering; D G Evans; H L DuPont; J J Vollet; D J Evans
Journal:  J Pediatr       Date:  1981-07       Impact factor: 4.406
  10 in total
  7 in total

1.  A recurring outbreak of Shigella sonnei among traditionally observant Jewish children in New York City: the risks of daycare and household transmission.

Authors:  V Garrett; K Bornschlegel; D Lange; V Reddy; L Kornstein; J Kornblum; A Agasan; M Hoekstra; M Layton; J Sobel
Journal:  Epidemiol Infect       Date:  2006-04-20       Impact factor: 2.451

2.  Usefulness of ribotyping in a molecular epidemiology study of shigellosis.

Authors:  M C Mendoza; M C Martín; M A González-Hevia
Journal:  Epidemiol Infect       Date:  1996-04       Impact factor: 2.451

Review 3.  Serum IgG antibodies to Shigella lipopolysaccharide antigens - a correlate of protection against shigellosis.

Authors:  Dani Cohen; Shiri Meron-Sudai; Anya Bialik; Valeria Asato; Sophy Goren; Ortal Ariel-Cohen; Arava Reizis; Amit Hochberg; Shai Ashkenazi
Journal:  Hum Vaccin Immunother       Date:  2019-05-09       Impact factor: 3.452

4.  Thymic independence of adaptive immunity to the intracellular pathogen Shigella flexneri serotype 2a.

Authors:  S S Way; A C Borczuk; M B Goldberg
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

Review 5.  Detoxified O-Specific Polysaccharide (O-SP)-Protein Conjugates: Emerging Approach in the Shigella Vaccine Development Scene.

Authors:  Dani Cohen; Shiri Meron-Sudai; Anya Bialik; Valeria Asato; Shai Ashkenazi
Journal:  Vaccines (Basel)       Date:  2022-04-24

6.  Accessory Genome Dynamics and Structural Variation of Shigella from Persistent Infections.

Authors:  Rebecca J Bengtsson; Timothy J Dallman; Hester Allen; P Malaka De Silva; George Stenhouse; Caisey V Pulford; Rebecca J Bennett; Claire Jenkins; Kate S Baker
Journal:  mBio       Date:  2021-04-27       Impact factor: 7.867

7.  Recent trends in the epidemiology of shigellosis in Israel.

Authors:  D Cohen; R Bassal; S Goren; T Rouach; D Taran; B Schemberg; N Peled; Y Keness; S Ken-Dror; V Vasilev; I Nissan; V Agmon; T Shohat
Journal:  Epidemiol Infect       Date:  2014-02-20       Impact factor: 4.434
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.